Please share this announcement with:

  • Medical Director, Laboratory Services
  • Administrative Director and Managers, Laboratory Services

Memo 20-06-CLIA: CMS SARS-CoV-2 Testing Comparison

KEY POINTS

  1. CMS is committed to taking critical steps to ensure America’s clinical laboratories can respond to the threat of COVID-19.
  2. Laboratories need a CLIA certificate to perform SARS-CoV-2 testing.
  3. Guidance on the different types of testing available for laboratories whether the tests are being offered under an EUA issued by the FDA and the CLIA certificates under which testing can be performed.

Read the memo here.

Abbott iStat FAQs


KEY POINTS

  • New frequently asked questions related to the Abbott iStat have been published on the CLIA website.

Read the document here.